Ennova Health Science and Technology

Ennova Health Science and Technology is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for cancer and other life-threatening diseases. The company leverages a proprietary structure-based drug design platform integrated with artificial intelligence to accelerate the development of high-potency small molecules and biologics. Their pipeline primarily targets well-validated oncogenic drivers and immune checkpoints, with a focus on overcoming resistance mechanisms in solid tumors. Ennova operates research and development facilities in China and the United States, aiming to deliver precision medicines to global markets.